Alprostadil
Links shared publicly online about this topic
NexMed To Discuss P2/3 Protocol For NexACT(R)-Based Alprostadil Treatment For Raynaud's Syndrome With The FDA
medicalnewstoday.com — “NexMed, Inc. (Nasdaq: NEXM), a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the U.S. Food & Drug Administration (FDA) has granted the Company” View full resource at medicalnewstoday.com
Most Recently Shared on May 19, 2010 at 1:13 am By:
MNT Dermatology News Dermatology and Health News
NexMed To Discuss P2/3 Protocol For NexACT(R)-Based Alprostadil Treatment For Raynaud's Syndrome With The FDA http://mnt.to/3CMb
Sihuan Pharmaceutical Obtains 30-Year Exclusive Distribution Rights For One Of The Best Selling Cardio-Cerebral Vascular Drugs In China
medicalnewstoday.com — “Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460), a leading pharmaceutical company with the largest cardio-cerebral vascular drug franchise in China by market share, today announced that its” View full resource at medicalnewstoday.com
Most Recently Shared on November 19, 2010 at 6:07 pm By:
MNT Drug Approvals Health News
Sihuan Pharmaceutical Obtains 30-Year Exclusive Distribution Rights For One Of The Best Selling Cardio-Cerebral Vascul... http://mnt.to/3MT8
NexMed Announces Pre-Clinical Study Showing Vitaros(R) Significantly Promotes Wound Healing
medicalnewstoday.com — “NexMed, Inc. (Nasdaq: NEXM), a specialty CRO with a pipeline of products based on the NexACT® technology, announced results from a pre-clinical study showing that Vitaros®, the Company's N” View full resource at medicalnewstoday.com
Most Recently Shared on May 14, 2010 at 12:06 pm By:
MNT Erectile Dysfunc Health News
NexMed Announces Pre-Clinical Study Showing Vitaros(R) Significantly Promotes Wound Healing http://mnt.to/3CBf #erectiledysfunction
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MNT Dermatology News
The latest dermatology / skin conditions news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Drug Approvals
The latest regulatory affairs / drug approvals news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Erectile Dysfunc
The latest erectile dysfunction news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
